About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tyrobptm1.1Viv
targeted mutation 1.1, Eric Vivier
MGI:2386271
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Tyrobptm1.1Viv/Tyrobptm1.1Viv B6.129P2-Tyrobptm1.1Viv MGI:3818484
hm2
Tyrobptm1.1Viv/Tyrobptm1.1Viv involves: 129P2/OlaHsd * BALB/cJ * C57BL/6 MGI:3818477
hm3
Tyrobptm1.1Viv/Tyrobptm1.1Viv involves: 129P2/OlaHsd * C57BL/6 MGI:3818418
cx4
Rag1tm1Mom/Rag1tm1Mom
Tyrobptm1.1Viv/Tyrobptm1.1Viv
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/10 MGI:3818486
cx5
Fcer1gtm1Rav/Fcer1gtm1Rav
Tyrobptm1.1Viv/Tyrobptm1.1Viv
involves: 129P2/OlaHsd * C57BL/6 MGI:3818420


Genotype
MGI:3818484
hm1
Allelic
Composition
Tyrobptm1.1Viv/Tyrobptm1.1Viv
Genetic
Background
B6.129P2-Tyrobptm1.1Viv
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tyrobptm1.1Viv mutation (1 available); any Tyrobp mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
nervous system
N
• despite the reduction in microglial cells, the number of astrocytes is normal
• at P10 or P15, the number of microglial cell numbers are decreased compared to in wild-type mice
• axon diameters are increased compared to in wild-type mice
• mice exhibit defects in myelin distribution and hypomyelination in the frontal brain regions compared to wild-type mice
• however, mice exhibit no evidence of oligodendrocyte degeneration, inflammation, microvascular changes or major axonal alterations
• the ratio of AMPA receptor excitatory postsynaptic current at -60 and +40 mV is increased compared to in wild-type mice
• mice exhibit an increased long term potentiation (LTP) with smaller decay compared to in wild-type mice without a difference in glutamate release probability at Schaffer collateral inputs
• mice exhibit a 3-fold increase in LTP and a 100% increase in NMDAR-independent LTP at Schaffer collateral synapses compared to wild-type mice

skeleton
• bone mineral content is increased compared to wild-type mice
• bone mineral density is increased compared to wild-type mice
• trabecular bone volume is doubled compared to controls
• increase in trabecular numbers resulting in a decrease in trabecular separation
• bone mass is increased 21% compared to in wild-type mice (J:129304)
• mild
• bone formation rates are reduced by more than 50% compared to in wild-type mice
• bone mineralizing surfaces are decreased compared to in wild-type mice
• however, mineral apposition rates are normal
• mice exhibit reduced bone remodeling due to defects in bone resorption (J:95232)
• following ovariectamy, mice exhibit an increased bone loss compared to in similarly treated wild-type mice (J:129304)
• osteoclast differentiation in vitro and function in vivo are impaired compared to in wild-type mice (J:95232)
• collagen type I degradation products are decreased compared to in wild-type mice (J:129304)
• decreased levels of deoxypyridinoline indicates impaired osteoclast-mediated bone resorption compared to in wild-type mice (J:95232)
• however, TRAP activity indicates that osteoclast numbers are normal (J:95232)
• in vitro, restored osteoclast differentiation by the presence of lymphocytes does not result in restored bone resorption as do wild-type cells (J:129304)

immune system
• bone marrow cells are unable to generate multinucleated osteoclasts or microglial cells under specific conditions unlike wild-type bone marrow cells
• however, bone marrow cells can be induced to form dendritic cells and macrophages
• at P10 or P15, the number of microglial cell numbers are decreased compared to in wild-type mice
• osteoclast differentiation in vitro and function in vivo are impaired compared to in wild-type mice (J:95232)
• collagen type I degradation products are decreased compared to in wild-type mice (J:129304)

homeostasis/metabolism
• mice treated with ifenprodil exhibit increased depression of NMDAR currents compared to similarly treated wild-type mice

hematopoietic system
• bone marrow cells are unable to generate multinucleated osteoclasts or microglial cells under specific conditions unlike wild-type bone marrow cells
• however, bone marrow cells can be induced to form dendritic cells and macrophages
• at P10 or P15, the number of microglial cell numbers are decreased compared to in wild-type mice
• osteoclast differentiation in vitro and function in vivo are impaired compared to in wild-type mice (J:95232)
• collagen type I degradation products are decreased compared to in wild-type mice (J:129304)

Mouse Models of Human Disease
DO ID OMIM ID(s) Ref(s)
Nasu-Hakola disease DOID:0090112 OMIM:221770
J:95232




Genotype
MGI:3818477
hm2
Allelic
Composition
Tyrobptm1.1Viv/Tyrobptm1.1Viv
Genetic
Background
involves: 129P2/OlaHsd * BALB/cJ * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tyrobptm1.1Viv mutation (1 available); any Tyrobp mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
immune system
• the number of CD11c+ dendritic cells is increased 2-fold in the intestinal lamina propria and dramatically increased in the subepithelial dome of the Peyer's patches compared to in wild-type mice
• the number of MHC class II+ cells with dendtritic morphology in the buccal mucosa and skin is increased compared to in wild-type mice
• however, the numbers of DEC205+ dendritic cells in the interfollicular T cell region, the accumulation of dendritic cells in the spleen and peripheral lymph nodes, and differentiation of dendrictic cells are normal
• NK cells exhibit severely impaired lysis of CHO cells and fail to lyse tumor target cells upon Ly49D antibody activations unlike wild-type NK cells
• natural cytoxicity of DX5+ splenocytes towards macrophage cell lines J774 and IC-21 is severely diminished compared to in wild-type cells
• however, natural cytotoxicity towards YAC-1, Bw15.02, RMA, and RMA/S cells and NK cell differentiation are normal
• mice exhibit a severely impaired contact sensitivity response following exposure to 2,4-dinitrofluoro-benzene compared to similarly treated wild-type mice

hematopoietic system
• the number of CD11c+ dendritic cells is increased 2-fold in the intestinal lamina propria and dramatically increased in the subepithelial dome of the Peyer's patches compared to in wild-type mice
• the number of MHC class II+ cells with dendtritic morphology in the buccal mucosa and skin is increased compared to in wild-type mice
• however, the numbers of DEC205+ dendritic cells in the interfollicular T cell region, the accumulation of dendritic cells in the spleen and peripheral lymph nodes, and differentiation of dendrictic cells are normal
• NK cells exhibit severely impaired lysis of CHO cells and fail to lyse tumor target cells upon Ly49D antibody activations unlike wild-type NK cells
• natural cytoxicity of DX5+ splenocytes towards macrophage cell lines J774 and IC-21 is severely diminished compared to in wild-type cells
• however, natural cytotoxicity towards YAC-1, Bw15.02, RMA, and RMA/S cells and NK cell differentiation are normal




Genotype
MGI:3818418
hm3
Allelic
Composition
Tyrobptm1.1Viv/Tyrobptm1.1Viv
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tyrobptm1.1Viv mutation (1 available); any Tyrobp mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• at E12, the mesometrial lymphoid aggregate of pregnancy is enlarged compared to in wild-type mice
• at E10, the decidua basalis is larger compared to in wild-type mice but, by E12, the decidua basalis is reduced compared to in wild-type mice
• at E10 in the decidua basalis
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy
• at E12, the decidual spiral arterial vessel to lumen area is increased compared to in wild-type mice
• embryo implantation sites are absent at E6 and E8
• at E12, thick-walled arteries are prominent in implantation site unlike in wild-type mice
• uterine NK cells fail to modify the spiral arteries of the deciduas as in wild-type mice
• fewer mice become pregnant following mating compared to wild-type mice

embryo
• at E12, the mesometrial lymphoid aggregate of pregnancy is enlarged compared to in wild-type mice
• at E10, the decidua basalis is larger compared to in wild-type mice but, by E12, the decidua basalis is reduced compared to in wild-type mice
• at E10 in the decidua basalis
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy
• at E12, the decidual spiral arterial vessel to lumen area is increased compared to in wild-type mice
• at E10 and E12

immune system
• at E10 in the decidua basalis
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy

hematopoietic system
• at E10 in the decidua basalis
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy

endocrine/exocrine glands
• at E10 in the decidua basalis
• at E10 and E12 in the mesometrial lymphoid aggregate of pregnancy




Genotype
MGI:3818486
cx4
Allelic
Composition
Rag1tm1Mom/Rag1tm1Mom
Tyrobptm1.1Viv/Tyrobptm1.1Viv
Genetic
Background
involves: 129P2/OlaHsd * 129S7/SvEvBrd * C57BL/6 * C57BL/10
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Rag1tm1Mom mutation (49 available); any Rag1 mutation (120 available)
Tyrobptm1.1Viv mutation (1 available); any Tyrobp mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
skeleton
• the number of trabeculae are increased compared to wild-type mice
• however, trabecular thickness is normal
• the space between trabeculae is reduced compared to in wild-type mice
• bone mass is increased 30% compared to in Tyrobptm1.1Viv homozygotes and 60% compared to in wild-type mice and Rag1tm1Mom homozygotes
• severe
• following ovariectamy, mice exhibit an increased bone loss compared to in similarly treated wild-type mice or Tyrobptm1.1Viv homozygotes
• collagen type I degradation products are decreased 17% compared to in wild-type mice

immune system
• collagen type I degradation products are decreased 17% compared to in wild-type mice

hematopoietic system
• collagen type I degradation products are decreased 17% compared to in wild-type mice




Genotype
MGI:3818420
cx5
Allelic
Composition
Fcer1gtm1Rav/Fcer1gtm1Rav
Tyrobptm1.1Viv/Tyrobptm1.1Viv
Genetic
Background
involves: 129P2/OlaHsd * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Fcer1gtm1Rav mutation (8 available); any Fcer1g mutation (26 available)
Tyrobptm1.1Viv mutation (1 available); any Tyrobp mutation (10 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
reproductive system
• at E12, the mesometrial lymphoid aggregate of pregnancy is smaller than in wild-type mice
• at E10, the decidua basalis is reduced compared to in wild-type mice
• at E10 in the deciduas basalis and at E12 in the mesometrial lymphoid aggregate of pregnancy
• at E10 and E12, the decidual spiral arterial vessel to lumen area is increased compared to in wild-type mice
• at E12, thick-walled arteries are prominent in implantation site unlike in wild-type mice
• uterine NK cells fail to modify the spiral arteries of the deciduas as in wild-type mice
• fewer mice of one line become pregnant following mating compared to wild-type mice
• midgestational (E10) fetal loss is greater than in wild-type mice
• however, mice derived from a different line exhibit normal pregnancy rates

embryo
• at E12, the mesometrial lymphoid aggregate of pregnancy is smaller than in wild-type mice
• at E10, the decidua basalis is reduced compared to in wild-type mice
• at E10 in the deciduas basalis and at E12 in the mesometrial lymphoid aggregate of pregnancy
• at E10 and E12, the decidual spiral arterial vessel to lumen area is increased compared to in wild-type mice
• at E10 and E12

immune system
• at E10 in the deciduas basalis and at E12 in the mesometrial lymphoid aggregate of pregnancy
• at E6 through E14 in the mesometrial triangle, mesometrial lymphoid aggregate of pregnancy and deciduas basalis

hematopoietic system
• at E10 in the deciduas basalis and at E12 in the mesometrial lymphoid aggregate of pregnancy

endocrine/exocrine glands
• at E10 in the deciduas basalis and at E12 in the mesometrial lymphoid aggregate of pregnancy





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
04/30/2024
MGI 6.23
The Jackson Laboratory